FDA Approvals in Oncology: January-March 2026
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Tag: Leukemia
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In February, the editors of AACR's journals highlighted studies on the FDA’s accelerated approval pathway, how metabolism impacts prostate...
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
The countdown to the new year is nearly upon us, but no need to count down to the last...
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
This month, the editors of AACR’s journals picked studies highlighting genetic parallels between cancer evolution and high-altitude physiology, data...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Twenty-one years ago this week, police officers, firefighters, paramedics, and volunteers converged on the remains of the World Trade...